Otsuka Holdings Co (STU:OS1) Cyclically Adjusted Revenue per Share: €18.70 (As of Mar. 2026)


STU:OS1 Otsuka Holdings Co Ltd STU:OS1
87 GF Score
Price €60.50
GF Value €45.14
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Otsuka Holdings Co Cyclically Adjusted Revenue per Share?

Otsuka Holdings Co STU:OS1 +0.83% 87 Cyclically Adjusted Revenue per Share is €18.70 as of Mar. 2026. GuruFocus rates STU:OS1 with a GF Score™ of 87/100 and a GF Value™ of €45.14 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Otsuka Holdings Co's adjusted revenue per share for the three months ended in Mar. 2026 was €6.509. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €18.70 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Otsuka Holdings Co's average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Otsuka Holdings Co was 6.90% per year. The lowest was 1.50% per year. And the median was 5.50% per year.

As of today (2026-07-12), Otsuka Holdings Co's current stock price is €60.50. Otsuka Holdings Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €18.70. Otsuka Holdings Co's Cyclically Adjusted PS Ratio of today is 3.24.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Otsuka Holdings Co was 3.44. The lowest was 1.35. And the median was 1.87.


Otsuka Holdings Co  (STU:OS1) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Otsuka Holdings Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=60.50/18.70
=3.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Otsuka Holdings Co was 3.44. The lowest was 1.35. And the median was 1.87.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Otsuka Holdings Co Cyclically Adjusted Revenue per Share Related Terms


Otsuka Holdings Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Otsuka Holdings Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co Cyclically Adjusted Revenue per Share Chart

Otsuka Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.27 19.19 18.50 18.88 18.13

Otsuka Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.41 18.79 18.63 18.13 18.70

STU:OS1 vs LLY, JNJ, ABBV: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Otsuka Holdings Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Otsuka Holdings Co's Cyclically Adjusted PS Ratio falls into.


STU:OS1
87GF Score
Otsuka Holdings Co Ltd STU:OS1
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otsuka Holdings Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Otsuka Holdings Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.509/112.7000*112.7000
=6.509

Current CPI (Mar. 2026) = 112.7000.

Otsuka Holdings Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 4.792 98.100 5.505
201609 4.886 98.000 5.619
201612 4.607 98.400 5.277
201703 4.282 98.100 4.919
201706 4.667 98.500 5.340
201709 4.524 98.800 5.160
201712 4.431 99.400 5.024
201803 4.158 99.200 4.724
201806 4.645 99.200 5.277
201809 4.652 99.900 5.248
201812 4.971 99.700 5.619
201903 4.613 99.700 5.214
201906 5.396 99.800 6.093
201909 5.568 100.100 6.269
201912 5.590 100.500 6.269
202003 5.263 100.300 5.914
202006 5.417 99.900 6.111
202009 5.508 99.900 6.214
202012 5.196 99.300 5.897
202103 4.799 99.900 5.414
202106 5.309 99.500 6.013
202109 5.528 100.100 6.224
202112 5.603 100.100 6.308
202203 5.369 101.100 5.985
202206 5.649 101.800 6.254
202209 5.869 103.100 6.415
202212 6.085 104.100 6.588
202303 5.773 104.400 6.232
202306 6.006 105.200 6.434
202309 6.208 106.200 6.588
202312 6.331 106.800 6.681
202403 5.879 107.200 6.181
202406 6.390 108.200 6.656
202409 7.217 108.900 7.469
202412 6.878 110.700 7.002
202503 6.748 111.100 6.845
202506 6.743 111.700 6.803
202509 6.926 112.000 6.969
202512 6.718 113.000 6.700
202603 6.509 112.700 6.509

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €18.70 mean?
Otsuka Holdings Co (STU:OS1) has a Cyclically Adjusted Revenue per Share of €18.70 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Otsuka Holdings Co and its competitors.
Is Otsuka Holdings Co's Cyclically Adjusted Revenue per Share too high?
Otsuka Holdings Co's current Cyclically Adjusted Revenue per Share is €18.70. Overall, Otsuka Holdings Co has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's Cyclically Adjusted Revenue per Share compare to LLY and JNJ?
Otsuka Holdings Co's Cyclically Adjusted Revenue per Share of €18.70 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Otsuka Holdings Co and its competitors. Otsuka Holdings Co's current Cyclically Adjusted Revenue per Share is €18.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (STU:OS1) is currently considered Significantly Overvalued. The stock's GF Value™ is €45.14, compared to a current price of €60.50 — trading 34% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €18.70. Otsuka Holdings Co's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Otsuka Holdings Co (STU:OS1), the current Cyclically Adjusted Revenue per Share is €18.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Otsuka Holdings Co (STU:OS1) Overvalued in 2026?

Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued. The current stock price of €60.50 is trading 34% above its estimated GF Value™ of €45.14. GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.

Key valuation signals for STU:OS1:

  • Cyclically Adjusted Revenue per Share: €18.70
  • GF Value™: €45.14 vs. price of €60.50 (34% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the STU:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Otsuka Holdings Co Business Description

Address 2-16-4 Konan, Shinagawa Grand Central Tower, Minato-ku, Tokyo, JPN, 108-8241
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
87GF Score

Get the complete analysis for STU:OS1

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.50
Price
€45.14
GF Value